Literature for carmaphycin B (T01.012 inhibitor)

(Topics flags: I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2017
1. LaMonte,G.M., Almaliti,J., Bibo-Verdugo,B., Keller,L., Zou,B.Y., Yang,J., Antonova-Koch,Y., Orjuela-Sanchez,P., Boyle,C.A., Vigil,E., Wang,L., Goldgof,G.M., Gerwick,L., O'Donoghue,A.J., Winzeler,E.A., Gerwick,W.H. and Ottilie,S.
   Development of a potent inhibitor of the Plasmodium proteasome with reduced mammalian toxicity
   J Med Chem60, 6721-6732. PubMed  Europe PubMed DOI  I
2014
2. Trivella,D.B., Pereira,A.R., Stein,M.L., Kasai,Y., Byrum,T., Valeriote,F.A., Tantillo,D.J., Groll,M., Gerwick,W.H. and Moore,B.S.
   Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor
   Chem Biol21, 782-791. PubMed  Europe PubMed DOI  I
2012
3. Pereira,A.R., Kale,A.J., Fenley,A.T., Byrum,T., Debonsi,H.M., Gilson,M.K., Valeriote,F.A., Moore,B.S. and Gerwick,W.H.
   The carmaphycins: new proteasome inhibitors exhibiting an alpha,beta-epoxyketone warhead from a marine cyanobacterium
   Chembiochem13, 810-817. PubMed  Europe PubMed DOI  I